Skip to content

Clinical trials

Completed Phase 1/2 Anxiety Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 1/2 Status: Completed Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20023
20041
20051
20061
20071
20081
20094
20103
20113
20122
20133
20142
20152
20161
20171
20182
20213
20221
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assaf-Harofeh Medical Center2
Biomind Labs Inc.2
University of South Florida2
Washington University School of Medicine2
Alliant International University1
Arizona State University1
Charite University, Berlin, Germany1
D'Or Institute for Research and Education1
Duquesne University1
GGZ Centraal1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders40
Stress Disorders, Post-Traumatic4
Mood Disorders3
Sleep Initiation and Maintenance Disorders3
Alcoholism2
Anxiety, Separation2
Back Pain2
Breast Neoplasms2
Cognitive Dysfunction2
Generalized Anxiety Disorder2

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.